This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Hillstream BioPharma’s 8K filing here.
About Hillstream BioPharma
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Read More
- Five stocks we like better than Hillstream BioPharma
- What is a Bond Market Holiday? How to Invest and Trade
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- What is the Dogs of the Dow Strategy? Overview and Examples
- TJX Companies Stock Poised to Hit a New High This Year
